Volume 55, Issue 4 pp. 526-531
Clinical Research

Modeling functional decline over time in sporadic inclusion body myositis

Lindsay N. Alfano DPT, PCS

Corresponding Author

Lindsay N. Alfano DPT, PCS

The Research Institute at Nationwide Children's Hospital, Center for Gene Therapy, 700 Children's Drive, Room AB1042, Columbus, Ohio, 43205 USA

Correspondence to: L.N. Alfano; e-mail: [email protected]Search for more papers by this author
Han Yin PhD, MS

Han Yin PhD, MS

The Research Institute at Nationwide Children's Hospital, Biostatistics Core, Columbus, Ohio, USA

Search for more papers by this author
Igor Dvorchik PhD

Igor Dvorchik PhD

The Research Institute at Nationwide Children's Hospital, Biostatistics Core, Columbus, Ohio, USA

Search for more papers by this author
Elizabeth G. Maus DPT

Elizabeth G. Maus DPT

The Research Institute at Nationwide Children's Hospital, Center for Gene Therapy, 700 Children's Drive, Room AB1042, Columbus, Ohio, 43205 USA

Search for more papers by this author
Kevin M. Flanigan MD

Kevin M. Flanigan MD

The Research Institute at Nationwide Children's Hospital, Center for Gene Therapy, 700 Children's Drive, Room AB1042, Columbus, Ohio, 43205 USA

Search for more papers by this author
Jerry R. Mendell MD

Jerry R. Mendell MD

The Research Institute at Nationwide Children's Hospital, Center for Gene Therapy, 700 Children's Drive, Room AB1042, Columbus, Ohio, 43205 USA

Search for more papers by this author
Linda P. Lowes PT, PhD

Linda P. Lowes PT, PhD

The Research Institute at Nationwide Children's Hospital, Center for Gene Therapy, 700 Children's Drive, Room AB1042, Columbus, Ohio, 43205 USA

Search for more papers by this author
First published: 11 August 2016
Citations: 14

This study was supported by Novartis Pharma AG.

ABSTRACT

Introduction: The ability to individualize recommendations or expectations of disease progression based on a patient's unique characteristics has merit for use in sporadic inclusion body myositis (sIBM). Methods: Fifty-five subjects with sIBM completed a battery of strength and functional outcomes at 2 study visits. These were used to develop mathematical models of disease progression in patients with sIBM for use in clinical and research settings. Results: The 6-minute walk test (6MWT) distance declined by an average of 27.5 meters (12%) per year. Significant factors that predict 6MWT were knee extension and plantarflexion strength and body weight, whereas the ability to stand from a chair was impacted by elbow extension strength. Stepping up on a curb was influenced by the patient's age at diagnosis and by knee extension. Statistical models to predict functional decline in sIBM were developed. Conclusion: Statistical models help explain the complex factors that influence decreased walking ability and other functional activities in sIBM. Muscle Nerve 55: 526–531, 2017

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.

click me